Clinical Trial Update: Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the effect of three multiple-dose regimens of BIA 9 1067 at steady-state on levodopa pharmacokinetics in Parkinson's disease; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 9-1067

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson's Disease (PD) | Phase 1 | Status: COMPLETED | Results posted: 2015-12-24